Orion Group (ORN)
(Delayed Data from NYSE)
$8.65 USD
+0.04 (0.46%)
Updated Jul 5, 2024 04:00 PM ET
After-Market: $8.66 +0.01 (0.12%) 7:58 PM ET
3-Hold of 5 3
C Value B Growth A Momentum A VGM
Fundamental Charts
About Price to Cash Flow
The Price to Cash Flow ratio or P/CF is price divided by its cash flow per share. It's another great way to determine whether a company is undervalued or overvalued with the denominator being cash flow. One of the reasons why some investors prefer the P/CF ratio over the P/E ratio is because the net income of the cash flow portion rightly adds depreciation and amortization back in since these are not cash expenditures. In contrast, the net income that goes into the earnings portion of the P/E ratio does not add these in, thus artificially reducing the income and skewing the P/E ratio. Like the P/E ratio, a lower number is considered better. A value under 20 is generally considered good.
ORN 8.65 +0.04(0.46%)
Will ORN be a Portfolio Killer in July?
Zacks Investment Research is releasing its prediction for ORN based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for ORN
Orion (ORN) Secures $63M Worth Contracts, Boosts Backlog
Why Orion Marine (ORN) Might be Well Poised for a Surge
ORN: What are Zacks experts saying now?
Zacks Private Portfolio Services
Here's What Could Help Orion Marine (ORN) Maintain Its Recent Price Strength
Here is What to Know Beyond Why Orion Group Holdings, Inc. (ORN) is a Trending Stock
Is Orion Group (ORN) Stock Outpacing Its Construction Peers This Year?
Other News for ORN
ORYZON Announces Voting Results from its 2024 Annual General Meeting of Shareholders
Oryzon Genomics Shareholders Approve Capital Boost
ORYZON Announces Presentation of Final Data From PORTICO, Vafidemstat’s Global Phase IIb Trial in Borderline Personality Disorder, at the 37th ECNP Annual Conference
Orion Minerals Pauses Trading Amid Capital Raise
Oryzon Genomics Finalizes Capital Increase